Session 1 – A Fascinating Year of Biotech Innovation and Investment
Date: 24 July (Wednesday) 14:00 - 16:30 Venue: 3F, Bldg. A, CTBC Financial Park, Ballroom A
Executive Vice President & Managing Director – Healthcare Practice
CDIB Capital Group
Robert is Managing Director and Co-Head of the Regional Healthcare Practice of CDIB Capital Group. Prior to joining CDIB he served as the Principal, Venture Investments at Johnson & Johnson Development Corporation (JJDC), responsible for the venture and private equity investments in life science and more broadly healthcare in Asia Pacific region. Prior to JJDC, Robert served as the Director of Business Development & Strategy in Greater China at GlaxoSmithKline, based in Beijing. Prior to that, Robert worked in the Global Corporate Development & Strategy team of Charles River Laboratories, based in Boston, USA, and executed many acquisition and investment transactions in the US, Europe and Asia.
Robert holds a PhD in Pharmacology from University of Rochester, an MBA from the University of Chicago Booth School of Business and a Master Degree in Medicine from Tongji Medical University. Robert also received the residency training in Urology at Union Hospital, Wuhan China.
Session Speech Title & Synopsis:
Global Trend of Biotech Investments & Innovations -2019
Discussion with panel experts on the new breakthrough drug development and technologies, investment focus and areas of interest.